| 000 | 01227 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515193240.0 | ||
| 264 | 0 | _c20100402 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1573-742X | ||
| 024 | 7 |
_a10.1007/s11239-009-0411-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeitz, Daniel S | |
| 245 | 0 | 0 |
_aUpdate on heparin: what do we need to know? _h[electronic resource] |
| 260 |
_bJournal of thrombosis and thrombolysis _cFeb 2010 |
||
| 300 |
_a199-207 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 |
_aThrombosis _xprevention & control |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWeitz, Jeffrey I | |
| 773 | 0 |
_tJournal of thrombosis and thrombolysis _gvol. 29 _gno. 2 _gp. 199-207 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11239-009-0411-6 _zAvailable from publisher's website |
| 999 |
_c19270930 _d19270930 |
||